Resource Utilization Among Glaucoma Patients in the UK Treated with Beta-Blocker and Non-Beta-Blocker Adjunctive Therapy: A Retrospective Cohort Analysis

IntroductionFew studies have examined outcomes and potential complications among glaucoma patients who are prescribed topical beta-blockers. This study examined resource usage (number of GP visits and hospitalizations) and diagnoses of respiratory or cardiovascular conditions among glaucoma patients prescribed beta-blockers compared to patients not prescribed beta-blockers.MethodsA retrospective cohort analysis was conducted using data from the UK Clinical Practice Research Datalink (CPRD) database over the period January 1, 2006 to March 31, 2014. Adult patients with at least one diagnosis of glaucoma were categorized into beta-blocker users and non-beta-blocker users. Beta-blocker users were further separated into patients that maintained beta-blocker therapy and patients that discontinued beta-blocker treatment in year 2 of the post-index period. The CPRD data was queried directly to obtain the number of GP visits, and hospitalizations were extracted by linking the CPRD and Hospital Episode Statistics (HES) patient-level data.ResultsIn the 12 months after being prescribed beta-blockers, patients that later discontinued beta-blocker treatment had a significantly higher average number of hospitalizations than patients that maintained beta-blocker therapy and the non-beta-blocker users (p < 0.05). In the year after beta-blocker initiation, there was a statistically significant within-group difference pre- and post-beta-blocker initiation for all groups, but the greatest number of GP visits occurred in the patients that subsequently discontinued beta-blocker treatment (mean 19.27). Patients that discontinued beta-blocker treatment were significantly more likely to have cardiovascular events than non-beta-blocker users in the post-index period (p < 0.05).ConclusionThis study suggests that the introduction of beta-blockers in a certain group of patients who later discontinue their use is associated with increased use of medical resources (higher number of GP visits and hospitalizations) in glaucoma patients in the UK, which may be indicative of a potential relationship between use of topical beta-blockers in glaucoma therapy and adverse outcomes.

[1]  H. Quigley.  Number of people with glaucoma worldwide. , 1996, The British journal of ophthalmology.

[2]  E. E. Hartmann,et al.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. , 2002, Archives of ophthalmology.

[3]  D. Tingey,et al.  Prescription of topical antiglaucoma agents for patients with contraindications to beta-blockers. , 2003, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[4]  H. Quan,et al.  Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data , 2005, Medical care.

[5]  D. Cook,et al.  The epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003 , 2006, British Journal of Ophthalmology.

[6]  S. Vinker,et al.  Prescription of Ocular β-Blockers in Patients with Obstructive Pulmonary Disease , 2006 .

[7]  H. Quigley,et al.  The number of people with glaucoma worldwide in 2010 and 2020 , 2006, British Journal of Ophthalmology.

[8]  S. Vinker,et al.  Prescription of ocular beta-blockers in patients with obstructive pulmonary disease: Does a central electronic medical record make a difference? , 2006, Clinical drug investigation.

[9]  M. C. Leske,et al.  Predictors of long-term progression in the early manifest glaucoma trial. , 2007, Ophthalmology.

[10]  C. Bunce,et al.  Causes of blind and partial sight certifications in England and Wales: April 2007–March 2008 , 2010, Eye.

[11]  J. Schmier,et al.  Medical Service Encounters and Payments Associated with Topical Adjunctive Therapy Use of Timolol for Glaucoma , 2012, Clinical Drug Investigation.

[12]  Rick Lukanz,et al.  Health and Social Care , 2018, Public Service Accountability.

[13]  Gretchen A. Stevens,et al.  Causes of vision loss worldwide, 1990-2010: a systematic analysis. , 2013, The Lancet. Global health.

[14]  Natalia Beloff,et al.  Exploiting the potential of large databases of electronic health records for research using rapid search algorithms and an intuitive query interface , 2013, J. Am. Medical Informatics Assoc..